Jordanian Association of Pharmaceutical Manufacturers and Medical Appliances (JAPM) in collaboration with Jordan Food and Drugs Association (JFDA) and with the support of USAID Jordan Economic Development Program (SABEQ) held this month the “3rd Middle East Bioequivalence Conference”.
The 3rd BE Conference invited representatives from health authorities in charge of BE studies in the region to address these issues and constraints, aiming for better harmony amongst different regulations, and improving acceptance rate of BE studies in these countries, in line with international regulations and in a bid to simplify the procedures.
“This conference is a discussion platform on BE studies, and aims to bridge gaps between industry, CROs and regulators in the Middle East. The Conference further harmonizes different national regulations and raises them to international standards, minimize debates, increase acceptance level and avoid potential losses due to rejections of bio studies. It also saves efforts and resources of all stakeholders,” said Ms Hanan Sboul, Secretary General, JAPM.












Recent Comments